IntegralBioScience | A Drug Discovery CRO & Contract Research Organization

Our teams, facility and working environment are geared towards making the innovation faster, efficient and successful.
As a drug discovery CRO, IBS is armed with experience, scientific tools, computer aided drug designing, expertise in chemistry, analytical instrumentation, in-vitro pharmacology and ADME.
Dedicated teams include the best and brightest talent trained at Indian/International elite universities for which achieving the scientific goals is the sole priority.

Introduction

Established in 2008, Integral Biosciences Pvt. Ltd (IBS) is a drug discovery CRO based out of Noida, UP, India, which offers end-to-end integrated drug discovery services to innovation focused biotech start-ups and small to mid-sized pharmaceutical companies.

Capabilities

IBS has capabilities to support medicinal chemistry, in-vitro screening and initial DMPK characterization of compounds...

News

Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of Bruton’s Tyrosine Kinase and Phosphoinositide 3-Kinase p110δ, ACS Medicinal Chemistry Letters (2016).

Introduction

Integral Biosciences (IBS) is a Delhi-based Indian biotech company, which operates a hybrid business model.

Capabilities

IBS has capabilities to support medicinal chemistry, in-vitro screening and initial DMPK characterization of compounds...

News

Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of Bruton’s Tyrosine Kinase and Phosphoinositide 3-Kinase p110δ, ACS Medicinal Chemistry Letters (2016).